Issue
Number 564
November 14, 2005
CONTENTS OF THIS ISSUE
- ACIP votes to recommend adult vaccination with
tetanus-diphtheria-pertussis vaccine (Tdap)
- New: CDC issues final VISs for injectable and
nasal-spray influenza vaccines and updates VIS instructions
- Update: CDC adds new fact sheet to its web section on
Guillain-Barre Syndrome and Menactra meningococcal vaccine
- New: Prepublication copies of the ninth edition of the
Pink Book now available for order
- CDC's satellite broadcast/webcast on Surveillance of
Vaccine-Preventable Diseases is set for December 8
- CDC updates its Influenza web section
- Multiple copies of the CD-ROM of NIP's Vaccine Storage &
Handling Toolkit now available through IAC
- New: GAO releases its report on the influenza vaccine
shortage of 2004-05
- New: November issue of CDC's Immunization Works
electronic newsletter now available on the NIP website
- Updated: IAC revises two of its professional-education
pieces
- Correction: Copyright information about ACOG's
guidelines on immunization during pregnancy
- International Conference on Emerging Infectious
Diseases planned for Atlanta on March 19-22, 2006
- Two new resources on global immunization now available
----------------------------------------------------------
Back to Top
---------------------------------------------------------------
ABBREVIATIONS: AAFP, American Academy of Family Physicians; AAP, American
Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices;
CDC, Centers for Disease Control and Prevention; FDA, Food and Drug
Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and
Mortality Weekly Report; NIP, National Immunization Program; VIS, Vaccine
Information Statement; VPD, vaccine-preventable disease; WHO, World Health
Organization.
---------------------------------------------------------------
(1 of 13)
November 14, 2005
ACIP VOTES TO RECOMMEND ADULT VACCINATION WITH TETANUS-DIPHTHERIA-PERTUSSIS
VACCINE (Tdap)
On November 9, CDC issued a press release announcing that ACIP voted to
recommend that adults receive the newly licensed
tetanus-diphtheria-pertussis vaccine (Tdap). Portions of the press release
are reprinted below.
**********************
November 9, 2005
ADVISORY COMMITTEE ON IMMUNIZATION PRACTICE RECOMMENDS ADULT VACCINATION
WITH NEW TETANUS, DIPHTHERIA, AND PERTUSSIS VACCINE (Tdap)
The Centers for Disease Control and Prevention's (CDC) Advisory Committee on
Immunization Practices (ACIP) at its recent meeting (October 26 and 27) in
Atlanta, voted to recommend that adults from 19 to 64 years of age be
vaccinated with a newly licensed adult booster tetanus, diphtheria, and
pertussis (whooping cough) vaccine (Tdap).
Under the ACIP recommendation, the Tdap vaccine would replace the currently
recommended tetanus-diphtheria vaccine that is used as the adult booster
vaccine. The new vaccine helps protect adults from pertussis, an illness
with severe and prolonged cough. It also reduces the risk of transmitting
pertussis to infants.
The ACIP recommended that adults receive a booster dose of Tdap vaccine
against tetanus, diphtheria, and pertussis if they have not received a
tetanus and diphtheria (Td) booster dose in ten or more years. Adults should
receive a single dose of Tdap to replace a single dose of Td. Pertussis
affects an estimated 600,000 adults every year, aged 20 to 64 years, and can
result in weeks of coughing, cracked ribs from severe coughing spells,
pneumonia, and other complications.
Tdap should also be given to adults who will have close contact with an
infant less than 12 months of age, ideally at least one month before
beginning close contact with infants. In situations when it is important to
protect against pertussis, intervals shorter than 10 years since the last Td
vaccination may be used. A 2-year interval between Td and Tdap is suggested
to reduce the risk of reactions following vaccination.
"Infants less than 12 months of age have a high risk of pertussis-related
complications, hospitalizations, and death. Vaccinating adult contacts may
reduce the risk of transmitting pertussis to infants," said Dr. Steve Cochi,
acting director of CDC's National Immunization Program. "Although pertussis
is most serious in infants, it can also be serious in adults. Even adults
who don't typically come in contact with young children should be
vaccinated. . . ."
Most reported pertussis cases among adolescents and adults occur because of
decline in protective immunity over time. Immunity against pertussis wanes
five to ten years after the last childhood vaccination. . . .
For more information on pertussis, visit
http://www.cdc.gov/nip/diseases/pertussis
**********************
To access the complete press release, go to:
http://www.cdc.gov/od/oc/media/pressrel/r051109.htm
---------------------------------------------------------------
Back to Top
(2 of 13)
November 14, 2005
NEW: CDC ISSUES FINAL VISs FOR INJECTABLE AND NASAL-SPRAY INFLUENZA VACCINES
AND UPDATES VIS INSTRUCTIONS
On November 5, CDC posted the final VISs for the trivalent inactivated
influenza vaccine (TIV; injectable) and the live attenuated intranasal
influenza vaccine (LAIV; nasal spray). The final influenza vaccine VISs are
dated 10/20/05. They may be used immediately; however, stocks of the interim
influenza VISs (dated 7/18/05) may be used through December 31, 2005.
Translation information. Only English-language versions of the final
influenza VISs are currently available. The final versions will be
translated into Spanish and other languages as soon as possible. For
continually updated information about the status of VISs in development, go
to NIP's web page Vaccine Information Statements News at
http://www.cdc.gov/nip/publications/VIS/vis-news.htm
VIS instructions. CDC has updated the one-page Instructions for the Use of
Vaccine Information Statements (dated 11/4/05). To access it, go to:
http://www.cdc.gov/nip/publications/vis/vis-Instructions.pdf
ACCESSING FINAL INFLUENZA VISs FROM THE CDC WEBSITE
To obtain a ready-to-print (PDF) version of the VIS for TIV (injectable), go
to:
http://www.cdc.gov/nip/publications/VIS/vis-flu.pdf
To obtain a ready-to-print (PDF) version of the VIS for LAIV (nasal spray),
go to:
http://www.cdc.gov/nip/publications/VIS/vis-flulive.pdf
ACCESSING FINAL INFLUENZA VISs FROM THE IAC WEBSITE
To obtain a ready-to-print (PDF) version of the VIS for TIV (injectable), go
to:
http://www.immunize.org/vis/2flu.pdf
To obtain a ready-to-print (PDF) version of the VIS for LAIV (nasal spray),
go to:
http://www.immunize.org/vis/liveflu.pdf
For information about the use of VISs, and for VISs in a total of 33
languages, visit IAC's VIS web section at
http://www.immunize.org/vis
---------------------------------------------------------------
Back to Top
(3 of 13)
November 14, 2005
UPDATE: CDC ADDS NEW FACT SHEET TO ITS WEB SECTION ON GUILLAIN-BARRE
SYNDROME AND MENACTRA MENINGOCOCCAL VACCINE
On November 10, CDC added a fact sheet for health professionals to its web
section Guillain-Barre Syndrome (GBS) and Menactra Meningococcal Vaccine.
Titled Guillain-Barre Syndrome Among Adolescents who Received Meningococcal
Conjugate Vaccine, the fact sheet has three sections: What you should know;
additional facts; and for more information.
To access the fact sheet, go to:
http://www.cdc.gov/nip/vacsafe/concerns/gbs/gbs-menactra-facts.htm
To access the web section, go to:
http://www.cdc.gov/nip/vacsafe/concerns/gbs/menactra.htm
---------------------------------------------------------------
Back to Top
(4 of 13)
November 14, 2005
NEW: PREPUBLICATION COPIES OF THE NINTH EDITION OF THE PINK BOOK NOW
AVAILABLE FOR ORDER
The ninth edition of the Pink Book (officially titled Epidemiology and
Prevention of Vaccine-Preventable Diseases) will be available February 2006.
The price is $25 for prepublication orders received by January 8, 2006.
After January 8, the price increases to $29.
The Pink Book is developed and published by NIP/CDC and distributed by the
Public Health Foundation. It provides physicians, nurses, pharmacists, and
other public health and healthcare professionals with comprehensive vaccine
information and recommendations, including the following:
-
General recommendations on immunizations including timing and spacing of
vaccines
-
Screening for contraindications and precautions such as pregnancy and HIV
infection
-
Specific strategies to achieve high vaccine coverage
-
Vaccine safety information
Information on the following is included in the ninth edition:
-
Pertussis (to reflect licensure of Tdap vaccine [tetanus-diphtheria-acellular
pertussis] and recommendations for its use)
-
Meningococcal (to reflect licensure of conjugate vaccine and
recommendations for its use)
-
Hepatitis A (to reflect the universal recommendation for children 12-23
months and reduction of the minimum age from two years to 12 months).
-
Measles, mumps, rubella, and varicella (to reflect the licensure of MMRV
vaccine [measles-mumps-rubella-varicella])
For additional information about the Pink Book and to order the ninth
edition online, go to:
http://bookstore.phf.org/prod463.htm You can also order by calling (877)
252-1200.
---------------------------------------------------------------
Back to Top
(5 of 13)
November 14, 2005
CDC'S SATELLITE BROADCAST/WEBCAST ON SURVEILLANCE OF VACCINE-PREVENTABLE
DISEASES IS SET FOR DECEMBER 8
The CDC course Surveillance of Vaccine-Preventable Diseases will be
broadcast and webcast on December 8 from 12 noon to 3:30PM ET. The
course is intended only for public health professionals with
responsibility for surveillance and case investigation of
vaccine-preventable diseases. Individual registration will begin
November 17.
Faculty includes William Atkinson, MD, MPH; John Moran, MD, MPH; Jane
Seward, MBBS, MPH; and Sandra Roush, MPH. All are with NIP/CDC. A live
Q&A session will allow participants nationwide to interact with course
instructors by phone, fax, and email.
For comprehensive course information, go to:
http://www.phppo.cdc.gov/PHTN/VPD-05 Questions about the course are
being taken by email at nipinfo@cdc.gov
To register online, go to:
http://www2a.cdc.gov/phtnonline Registration questions are being
taken by phone at (800) 418-7246 and by email at
ce@cdc.gov
---------------------------------------------------------------
Back to Top
(6 of 13)
November 14, 2005
CDC UPDATES ITS INFLUENZA WEB SECTION
CDC recently updated three pages of its Influenza web section:
-
"Questions & Answers: Vaccine Supply and Prioritization
Recommendations for the U.S. 2005-06 Influenza Season" (11/10/05)
-
"Recent Avian influenza outbreaks in Asia and Europe" (11/9/05 and
11/7/05)
-
"FluSurge" (11/7/05)
To access these materials, go to:
http://www.cdc.gov/flu/whatsnew.htm#updated and click on the pertinent
links.
To access a broad range of continually updated influenza information, go to:
http://www.cdc.gov/flu
---------------------------------------------------------------
Back to Top
(7 of 13)
November 14, 2005
MULTIPLE COPIES OF THE CD-ROM OF NIP'S VACCINE STORAGE & HANDLING
TOOLKIT NOW AVAILABLE THROUGH IAC
IAC is now offering multiple copies of the CD-ROM of NIP's recently
updated Vaccine Storage & Handling Toolkit. The toolkit features 11
chapters of information, numerous online resources, and two videos (on
the CD): (1) How to Protect Your Vaccine Supply (Updated in June 2005)
and (2) 10 Top Vaccine Storage and Handling Errors.
NOTE: One copy of the CD-ROM is available at no cost from CDC. To
order, go to:
http://www2.cdc.gov/nchstp_od/PIWeb/niporderform.asp
Copies of the toolkit CD are priced at $15 through IAC. For ordering
information, including placing online orders for up to 10 copies, go
to:
https://www.immunize.org/vachandling/cdorder.htm
Special discount pricing is available for 11 or more copies. For
information, call (651) 647-9009.
To view the toolkit on the NIP website, go to:
http://www2a.cdc.gov/nip/isd/shtoolkit/splash.html
PLEASE NOTE: NIP is no longer distributing the videotape How to
Protect Your Vaccine Supply as a discrete product, separate from the
toolkit--but IAC is. To order it separately, contact IAC at
https://www.immunize.org/vachandling/tapeorder.htm (online order
form), admin@immunize.org
(email), (651) 647-9131 (fax), or (651) 647-9009 (phone).
---------------------------------------------------------------
Back to Top
(8 of 13)
November 14, 2005
NEW: GAO RELEASES ITS REPORT ON THE INFLUENZA VACCINE SHORTAGE OF
2004-05
In September, the Government Accountability Office (GAO) issued its
report on the influenza vaccine shortage of 2004-05. It is titled
"Influenza Vaccine: Shortages in 2004-05 Season Underscore Need for
Better Preparation." The report highlight is reprinted below in its
entirety.
************************
WHAT GAO FOUND
Federal, state, and local health officials took several actions
beginning in October 2004 to help ensure that individuals at high risk
of severe complications from influenza had access to vaccine. Federal
officials, for example, quickly revised vaccination recommendations to
target available vaccine to high-risk individuals and to other
priority groups. Additional actions were aimed to distribute vaccine
expeditiously and to communicate with providers and the public as
events unfolded and vaccine supplies changed. Beginning in
mid-December, health officials took steps to distribute additional
vaccine, broadening recommendations on who should be vaccinated.
Although these actions helped achieve vaccination rates approaching
past levels for certain priority groups, such as those aged 65 years
and older, several lessons emerged, including some that could help
with future shortages. First, unless planning for problems is already
in place, action is delayed. CDC's lack of a contingency plan
contributed to delays and uncertainty about how to ensure that
high-risk individuals had access to vaccine. Second, when actions
occur late in the influenza season, they are likely to have little
effect. Third, effective response requires communication that is both
clear and consistent. CDC has taken a number of steps, including
issuing interim guidelines in August 2005, to respond to possible
future shortages. It is too early, however, to assess the
effectiveness of these efforts in coordinating actions of federal,
state, and local health agencies and others.
In commenting on a draft of this report, HHS [the Department of Health
and Human Services] concurred with GAO's finding that contingency
planning would improve response efforts, and the agency indicated that
additional preparations were under way.
************************
To access the complete 43-page report, go to:
http://www.gao.gov/new.items/d05984.pdf
---------------------------------------------------------------
Back to Top
(9 of 13)
November 14, 2005
NEW: NOVEMBER ISSUE OF CDC'S IMMUNIZATION WORKS ELECTRONIC NEWSLETTER
NOW AVAILABLE ON THE NIP WEBSITE
The November issue of Immunization Works, a monthly email newsletter
published by CDC, is available on NIP's website. The newsletter offers
members of the immunization community non-proprietary information
about current topics. CDC encourages its wide dissemination.
Some of the information in the November issue has already appeared in
previous issues of IAC Express. Following is the text of one article
we have not covered.
************************
OTHER IMMUNIZATION NEWS
INFLUENZA VACCINE SUPPLY UPDATE: Influenza vaccine manufacturers
expect to produce more than 80 million doses of influenza vaccine this
year, and as of the end of October, more than 57 million doses have
been distributed. However, many providers still do not have any
vaccine and others have only a portion of their order. Because a
portion of the vaccine distribution has been delayed this year,
healthcare professionals are encouraged to continue to vaccinate their
patients into December as vaccine becomes available. Influenza peaks
most often in January and February so the coming weeks on into
December afford opportunities for vaccination. For the latest
information about the influenza vaccine supply, as well as links to
weekly surveillance reports, press releases, and educational
materials, please visit CDC's influenza website at
http://www.cdc.gov/flu
************************
To access the complete November issue from the NIP website, go to:
http://www.cdc.gov/nip/news/newsltrs/imwrks/2005/200511.htm
---------------------------------------------------------------
Back to Top
(10 of 13)
November 14, 2005
UPDATED: IAC REVISES TWO OF ITS PROFESSIONAL-EDUCATION PIECES
In October, IAC revised two of its professional-education pieces: (1)
Administering Vaccines: Dose, Route, Site, and Needle Size and (2)
Vaccines and Related Products Distributed in the United States. Both
pieces now reflect information about newly licensed vaccines.
(1) Administering Vaccines: Dose, Route, Site, and Needle Size now
includes information about ProQuad, the newly licensed
measles-mumps-rubella-varicella vaccine.
To access a ready-to-print (PDF) version of it, go to:
http://www.immunize.org/catg.d/p3085.pdf
To access a web-text (HTML) version, go to:
http://www.immunize.org/catg.d/p3085.htm
(2) Vaccines and Related Products Distributed in the United States has
been updated with current information on all vaccines and biologics
distributed in the United States.
To access a ready-to-print (PDF) version of it, go to:
http://www.immunize.org/catg.d/2019prod.pdf
No web-text (HTML) version is available.
---------------------------------------------------------------
Back to Top
(11 of 13)
November 14, 2005
CORRECTION: COPYRIGHT INFORMATION ABOUT ACOG'S GUIDELINES ON
IMMUNIZATION DURING PREGNANCY
In the IAC Express of April 28, 2003, IAC erroneously stated that the
document titled "Immunization During Pregnancy" is in the public
domain. In fact, the American College of Obstetricians and
Gynecologists (ACOG) holds the copyright to the document. The document
is ACOG Committee Opinion No. 282. It was published in the January
2003 issue of the journal Obstetrics & Gynecology (vol. 101:207-12),
an ACOG publication. No part of the document may be reproduced, stored
in a retrieval system, or transmitted, in any form or by any means,
electronic, mechanical, photocopying, recording, or otherwise, without
prior written permission from the publisher. IAC regrets the error and
any inconvenience it may have caused ACOG or IAC Express readers.
To access a ready-to-print (PDF) version of the opinion from the ACOG
website, go to:
http://www.acog.org/from_home/publications/misc/bco282.pdf
To access a web-text (HTML) version of it, go to:
http://www.acog.org/from_home/publications/misc/bco282.cfm
To access the ACOG home page, go to:
http://www.acog.org
---------------------------------------------------------------
Back to Top
(12 of 13)
November 14, 2005
INTERNATIONAL CONFERENCE ON EMERGING INFECTIOUS DISEASES PLANNED FOR
ATLANTA ON MARCH 19-22, 2006
CDC published "Notice to Readers: Fifth International Conference on
Emerging Infectious Diseases" in the November 11 issue of MMWR. The
notice is reprinted below in its entirety.
***********************
CDC, the American Society for Microbiology, the Council of State and
Territorial Epidemiologists, the Association of Public Health
Laboratories, and the World Health Organization will cosponsor the
Fifth International Conference on Emerging Infectious Diseases, March
19-22, 2006, at the Marriott Marquis Hotel in Atlanta, Georgia. The
conference will explore current research, surveillance, and prevention
and control programs addressing all aspects of emerging infectious
diseases. Attendance is limited to 2,500 participants.
The conference will include general and plenary sessions, symposia,
panels of speakers, oral and poster presentations, and exhibits. The
deadline for submitting abstracts for presentations is December 2,
2005. Abstracts should address new, reemerging, or drug-resistant
infectious diseases that affect human health. The deadline for
late-breaker abstracts is February 1, 2006.
Information about abstract submission is available at
http://www.iceid.org/abstractsubmission.htm Registration
information is available at
http://www.iceid.org and by email at
meetinginfo@asmusa.org or
thj0@cdc.gov
***********************
To access a web-text (HTML) version of the notice, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5444a7.htm
To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5444.pdf
To receive a FREE electronic subscription to MMWR (which includes new
ACIP statements), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html
---------------------------------------------------------------
Back to Top
(13 of 13)
November 14, 2005
TWO NEW RESOURCES ON GLOBAL IMMUNIZATION NOW AVAILABLE
The IMMUNIZATIONbasics Project recently announced the launch of its new
website (http://www.immunizationbasics.jsi.com).
The website has information about the project, its priorities, activities,
partners, and staff. It makes up-to-date information and resources on
routine immunization and immunization financing available to users. The
project is funded by the U.S. Agency for International Development (USAID).
To be added to the IMMUNIZATIONbasics mailing list, send an email to
ImmBasics_Info@jsi.com and type
"subscribe" in the subject line.
The September issue of Global HealthLink, the magazine of the Global Health
Council, is dedicated to child health. It includes an immunization article,
"Vaccinating the World's Children: A Public Health 'Best Buy'," written by
Robert Steinglass, technical director of IMMUNIZATIONbasics.
To read the article online, go to:
http://www.globalhealth.org/reports/report.php3?id=210
To visit the homepage of the Global Health Council's website, go to:
http://www.globalhealth.org |
